FastWave Medical picks up another IVL patent
May 20, 2024
FastWave Medical announced that the United States Patent and Trademark Office (USPTO) issued it another intravascular lithotripsy (IVL) utility patent.
FastWave Medical announced that the United States Patent and Trademark Office (USPTO) issued it another intravascular lithotripsy (IVL) utility patent.
The invention provides an effective way to shave and remove the hair from a surgical incision site
Medtronic (NYSE: MDT)+
officials say the company received FDA clearance for the next-generation PillCam Genius SB capsule endoscopy kit.
A large international team of micro-engineers, medical technologists, and neurosurgeons, has designed, built and tested a new type of probe that can be used to take pictures from inside arteries in the brain.
ADDISON, Texas , May 16, 2024 /PRNewswire/ — FX received 510k clearance for its full-wedge augmented glenoid baseplates. The newly cleared baseplates bring 6 new options to the previously cleared portfolio. There are now a combined total of 18 glenoid baseplate options to the market to address a variety of surgeon needs. Augmented glenoid baseplate options have continued to become a growing solution for surgeons to address bone loss, defects, or complicated morphologies of the glenoid.
CARLSBAD, Calif., May 15, 2024 /PRNewswire/ — DCN Dx, a leading contract research organization for in vitro diagnostics, today acknowledges the FDA’s Emergency Use Authorization (EUA) of the WELLlife™ COVID-19/Influenza A&B Test, developed by Wondfo USA. This important authorization will enable healthcare professionals to differentiate rapidly between COVID-19 and influenza infections, enhancing patient care at the point-of-care.
How do tumors react to a certain therapeutic approach? Knowing this before the start of a therapy would be of enormous value for people suffering from cancer as well as for the doctors treating them.
A filter made from yeast encapsulated in hydrogels can quickly absorb lead as water flows through it.
The approval allows women to self-collect vaginal specimens for HPV testing in a health care setting, which could include non-traditional locations such as a retail pharmacy or mobile clinic.
Butterfly Network (NYSE:BFLY) announced today that it launched its first specialty product, the iQ+ Bladder portable ultrasound.